We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Statins May Slow the Effects of Alzheimer's Disease

Nymox has Global Patent Rights for Statin Drugs for the Treatment and Prevention of Alzheimer's Disease.
News

Scientists Uncover Cancer Cell Communication

Researchers have discovered the structure of the molecular switch that controls communication between tumour cells.
News

Predictive Medicine, Pharmacogenomic Testing, and Prenatal Genetic Screening Support Growth of the Genetic Diagnostics Market

New analysis from Frost & Sullivan, reveals that the predictive medicine, pharmacogenomic, and prenatal and newborn screening will experience significant growth over the next decades.
News

CTT Enters Into R&D Agreement With GE Healthcare

GE Healthcare and CTT will consider exploring a broader use of the CTT technology in medical imaging.
News

Transgenomic's Technology Enable Detection of Low-Level Mutation in Mast Cell Leukemia

Use of Transgenomic's technology enabled detection of disease-associated genetic mutation at several post-therapy time points.
News

Cedara to Showcase Applications That Enable Personalized Cancer Treatment

Cedara will introduce a clinical product line named Cedara OncologyWorks at this year's ASTRO conference.
News

Tm Bioscience to Supply PathGroup with Tag-It™ Reagents

Using the reagents from Tm Bioscience, PathGroup have developed an upgraded CF assay.
News

NIH Renews Its Pharmacogenetics Research Network

The NIH anticipates spending $150 million over five years to renew its Pharmacogenetics Research Network.
News

Duke Researchers Uncover Genetic Link to Stroke After Heart Surgery

Patients with a specific combination of polymorphisms in genes responsible for the production of C-reactive protein (CRP) and interleukin-6 (IL-6) suffered stroke at three times higher rate.
News

Patent Application for Biomarker-based Method to Diagnose Alzheimer's Disease

The patent application is being filed in conjunction with major research institutions in the Houston area, with Power3 having an exclusive license to commercialize the technology involved.
Advertisement